Advertisement

CAR T-Cell Therapy for Patients With CLL/SLL: TRANSCEND CLL 004
Posted: 09/06/2023 | By: Chase Doyle

In a study published by Siddiqi et al in The Lancet, researchers evaluated the efficacy and safety of lisocabtagene maraleucel in patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

Question 1 of 5

Who were the participants in the TRANSCEND CLL 004 study?

Choose 1

A
Patients diagnosed with either chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
B
Patients aged 18 years or older with relapsed or refractory CLL or SLL who had received at least two previous lines of therapy
C
Patients who had never received treatment for CLL or SLL
D
Patients diagnosed with acute lymphoblastic leukemia

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage